Related Experiment Video
Updated: May 28, 2025
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Medical Cannabis Use Adjunct to Standard of Care in a Residential Substance Use Recovery Program: A Pilot Study
Florriann C Fehr1, Lindsay A Lo2, Christopher C Nelson3
1School of Nursing, Thomson Rivers University, Kamloops, British Columbia, Canada.
Objective:
The purpose of this study was to investigate the experiences of a novel adjunctive medical cannabis (MC) intervention within a residential substance use recovery program.
Method:
This qualitative study included interviews and validated self-reports with clients (N = 14) at baseline, 1 month, and 3 months after receiving adjunctive medical cannabis treatment in addition to standard of care. Interviews with program staff (N = 7) supplemented the assessment of barriers and facilitators to program delivery.
Results:
Clients reported that the cannabis substitution program demonstrates promise to help reduce problematic substance use by reducing drug cravings and assisting with pain and other comorbid symptoms. The program also helped to destigmatize MC use. Staff reports highlighted the importance of MC education, clear guidelines for dispensing MC, and an accessible framework for program delivery to facilitate effective uptake of this novel intervention.
Conclusions:
This study provides preliminary evidence for the feasibility of integrating MC in a supportive residential recovery program. Important factors for success include the provision of cannabis education, developing a clear organizational framework, and establishing evidence-informed policies within the context of substitution therapy and harm reduction. Further research to more formally evaluate integrating MC in residential substance use treatment is encouraged.
